SHANGHAI (Reuters) - Chinese authorities have launched a year-long crackdown on practitioners of unregistered cosmetic surgery, the official China Daily said on Wednesday.
The new campaign, launched by the country's health ministry in conjunction with internet, drug safety and industry regulators, will also focus on illegal advertising and the unauthorised production and supply of drugs and appliances used in cosmetic surgery, the paper said.
The report said there are tens of thousands of cosmetic surgery practitioners in China, but fewer than 3,000 are registered with the authorities.
It said unlicensed facilities are responsible for more than 60 percent of serious medical complications arising from cosmetic procedures, with some patients known to have gone blind as a result of improperly administered injections.
In a document published last weekend on its website (http://www.moh.gov.cn), China's National Health and Family Planning Commission said "lawless elements" had been involved in the illegal manufacture and use of cosmetic drugs like collagen and botulinum. It said it would establish a blacklist and punish firms involved in illegal practices.
(Reporting by David Stanway; Editing by Michael Perry)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
